Search Results - "Kumar, Sushma"

Host-gut microbiota derived secondary metabolite mediated regulation of Wnt/β-catenin pathway: a potential therapeutic axis in IBD and CRC by Kumar, Sushma S, Fathima, Ashna, Srihari, Preeti, Jamma, Trinath

“…The intestinal tract encompasses one of the largest mucosal surfaces with a well-structured layer of intestinal epithelial cells supported by a network of…”
Get full text

Molnupiravir: Mechanism of action, clinical, and translational science by Maas, Brian M., Strizki, Julie, Miller, Randy R., Kumar, Sushma, Brown, Michelle, Johnson, Matthew G., Cheng, Mickie, De Anda, Carisa, Rizk, Matthew L., Stone, Julie A.

“…Molnupiravir is an oral prodrug of the broadly active, antiviral ribonucleoside analog N‐hydroxycytidine (NHC). The primary circulating metabolite NHC is taken…”
Get full text

Stranded: A Mainstream VR Quantum Game For Novices by Sreekuttan, L S, Thampy, Rohit P, Thota, Sairupa, Mohan Sharma, Adarsh, Tarun Vikas, Vinnakota, John Chemban, Jowin, Raj Kumar, Sushma, Bhattacharya, Supratip

“…In the larger picture of quantum technology, quantum education is mainly overlooked. We are developing an explorative puzzle-based VR quantum game, named…”
Get full text

Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus-1 Infection: Week 48 Results of the DRIVE-AHEAD Trial by Orkin, Chloe, Squires, Kathleen E, Molina, Jean-Michel, Sax, Paul E, Wong, Wing-Wai, Sussmann, Otto, Kaplan, Richard, Lupinacci, Lisa, Rodgers, Anthony, Xu, Xia, Lin, Gina, Kumar, Sushma, Sklar, Peter, Nguyen, Bach-Yen, Hanna, George J, Hwang, Carey, Martin, Elizabeth A

“…In Human Immunodeficiency Virus-1 treatment-naive adults, a fixed combination of doravirine/lamivudine/tenofovir disoproxil fumarate demonstrated non-inferior…”
Get full text

Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (TDF) Versus Efavirenz/Emtricitabine/TDF in Treatment-naive Adults With Human Immunodeficiency Virus Type 1 Infection: Week 96 Results of the Randomized, Double-blind, Phase 3 DRIVE-AHEAD Noninferiority Trial by Orkin, Chloe, Squires, Kathleen E, Molina, Jean-Michel, Sax, Paul E, Sussmann, Otto, Lin, Gina, Kumar, Sushma, Hanna, George J, Hwang, Carey, Martin, Elizabeth, Teppler, Hedy

“…Doravirine (DOR) is a nonnucleoside reverse-transcriptase inhibitor. In the phase 3 DRIVE-AHEAD trial in treatment-naive adults with human immunodeficiency…”
Get full text

Progesterone Induces Calcitonin Expression in the Baboon Endometrium Within the Window of Uterine Receptivity by KUMAR, Sushma, BRUDNEY, Allison, CHEON, Yong-Pil, FAZLEABAS, Asgerally T, BAGCHI, Indrani C

“…The mammalian uterus can accept a developing blastocyst for implantation only within a limited period of time, termed the receptive phase. Our previous studies…”
Get full text

Soft Colloidal Scaffolds Capable of Elastic Recovery after Large Compressive Strains by Rajamanickam, Raja, Kumari, Sushma, Kumar, Deepak, Ghosh, Shankar, Kim, Jong Chul, Tae, Giyoong, Sen Gupta, Sayam, Kumaraswamy, Guruswamy

“…Assemblies of inorganic or glassy particles are typically brittle and cannot sustain even moderate deformations. This restricts the use of such materials to…”
Get full text

Efficacy, safety and central nervous system effects after switch from efavirenz/tenofovir/emtricitabine to doravirine/tenofovir/lamivudine by Nelson, Mark, Winston, Alan, Hill, Andrew, Mngqibisa, Rosie, Bassa, Ayesha, Orkin, Chloe, Rassool, Mohammed, Rodgers, Anthony, Teal, Valerie, Kumar, Sushma, Teppler, Hedy

“…Doravirine is an alternative treatment option for individuals who do not tolerate efavirenz. We assessed efficacy, safety, and CNS effects in adults with HIV-1…”
Get full text

Once-daily Doravirine in Human Immunodeficiency Virus Type 1–Infected, Antiretroviral-naive Adults: An Integrated Efficacy Analysis by Orkin, Chloe, Molina, Jean-Michel, Lombaard, Johan, DeJesus, Edwin, Rodgers, Anthony, Kumar, Sushma, Martin, Elizabeth, Hanna, George, Hwang, Carey

“…Abstract Background Doravirine (DOR) demonstrated noninferior efficacy to darunavir plus ritonavir (DRV+r) and efavirenz (EFV) in 2 ongoing phase 3 trials:…”
Get full text

Review of Doravirine Resistance Patterns Identified in Participants During Clinical Development by Martin, Elizabeth Anne, Lai, Ming-Tain, Ngo, Winnie, Feng, Meizhen, Graham, Donald, Hazuda, Daria J., Kumar, Sushma, Hwang, Carey, Sklar, Peter, Asante-Appiah, Ernest

“…BACKGROUND:Doravirine (DOR) is a novel non-nucleoside reverse transcriptase inhibitor (NNRTI) approved for the treatment of HIV-1 infection in patients with no…”
Get full text

Causal Beliefs, Acculturation and Mental Health Stigma Among Indian Immigrants in the United States by Ramesh Kumar, Sushma

“…Mental health stigma continues to remain a challenge for those individuals with mental illness and often is a barrier towards help-seeking and social…”
Get full text

Efficacy, safety and CNS effects after switch from efavirenz/tenofovir/emtricitabine to doravirine/tenofovir/lamivudine in a randomized controlled trial by Nelson, Mark, Winston, Alan, Hill, Andrew, Mngqibisa, Rosie, Bassa, Ayesha, Orkin, Chloe, Rassool, Mohammed, Rodgers, Anthony, Teal, Valerie, Kumar, Sushma, Teppler, Hedy

Get full text

Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naive Adults With HIV-1 and Transmitted Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations by Wong, Alexander, Goldstein, Deborah, Mallolas, Josep, DeJesus, Edwin, Johnson, Margaret, Molina, Jean-Michel, Pozniak, Anton, Rodgers, Anthony, Teal, Valerie, Hepler, Deborah, Kumar, Sushma, Sklar, Peter, Hanna, George J, Hwang, Carey, Badshah, Cyrus, Teppler, Hedy

“…Supplemental Digital Content is Available in the Text…”
Get full text

Once-daily Doravirine for Initial Treatment of Adults Living With Human Immunodeficiency Virus–1: An Integrated Safety Analysis by Thompson, Melanie, Orkin, Chloe, Molina, Jean-Michel, Sax, Paul, Cahn, Pedro, Squires, Kathleen, Xu, Xia, Rodgers, Anthony, Kumar, Sushma, Teppler, Hedy, Martin, Elizabeth, Hanna, George, Hwang, Carey

“…Abstract Background A prespecified integrated safety analysis was conducted for 3 doravirine (DOR) double-blind trials (Phase IIb: P007 [NCT01632345]; Phase…”
Get full text

Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) Maintains HIV-1 Virologic Suppression Through 48 Weeks: Results of the DRIVE-SHIFT Trial by Johnson, Margaret, Kumar, Princy, Molina, Jean-Michel, Rizzardini, Giuliano, Cahn, Pedro, Bickel, Markus, Mallolas, Josep, Zhou, Yan, Morais, Cristiana, Kumar, Sushma, Sklar, Peter, Hanna, George J, Hwang, Carey, Greaves, Wayne

“…BACKGROUND:Doravirine is a novel, nonnucleoside reverse transcriptase inhibitor with demonstrated efficacy in treatment-naive adults with HIV-1. METHODS:In…”
Get full text

Preliminary studies on the effect of nanoparticle seed treatments on seed quality attributes and yield in chickpea by KUMAR, SUSHMA MUDLUPURA, YADAV, SHIV, YADAV, SANGITA, CHOUDHARY, RAVISH, LAL, SANDEEP, BHARADWAJ, CHELLAPILLA, HUSSAIN, ZAKIR, KUMAR, PRIYA RANJAN

Get full text

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial by Squires, Kathleen, Cahn, Pedro, Lombaard, Johan, DeJesus, Edwin, Lai, Ming-Tain, Rodgers, Anthony, Kumar, Sushma, Sklar, Peter, Nguyen, Bach-Yen, Hanna, George J, Hwang, Carey, Martins, Marcelo, Bloch, Mark Theo, Baker, David Alfred, Roth, Norman, Moore, Richard James, McMahon, James, Rieger, Armin, Zoufaly, Alexander, Zangerle, Robert, Smaill, Fiona, Rachlis, Anita, Perez, Carlos, Campos Barker, Maria Isabel E., Wolff Reyes, Marcelo, Laursen, Alex Lund, Molina, Jean-Michel, Yazdanpanah, Yazdan, Cotte, Laurent, Raffi, Francois, Morlat, Philippe, Girard, Pierre-Marie, Katlama, Christine, Rockstroh, Juergen K., Arasteh, Keikawus, Stoehr, Albrecht, Stellbrink, Hans-Juergen, Stoll, Matthias, Schuermann, Dirk, Faetkenheuer, Gerd, Bogner, Johannes, Gori, Andrea, Coltan, Gabriel, Constandis, Felicia, Erscoiu, Simona Manuela, Pokrovsky, Vadim Valentinovich, Shuldyakov, Andrey Anatolyevich, Ryamova, Elena Pavlovna, Kulagin, Valeriy Viktorovich, Tsybakova, Olga Aleksandrovna, Orlova-Morozova, Elena, Shimonova, Tatyana Evgenyevna, Kozyrev, Oleg Anatolyevich, Orrell, Catherine, Lombaard, Johannes Jurgens, Botes, Margaretha Elizabeth, Portilla, Joaquin, Gatell, Josep Maria, Perez, Maria Jesus, Arribas, Jose Ramon, Negredo, Eugenia, Podzamczer, Daniel, Troya, Jesus, De los Santos, Ignacio, Berenguer, Juan, Williams, Ian G., Johnson, Margaret A., Schembri, Gabriel, Gompels, Mark, Fox, Julie Meriel, Taylor, Steven John, Kegg, Stephen, Hagins, Debbie P., Osiyemi, Olayemi O., Prelutsky, David James, Ramgopal, Moti N., Dretler, Robin, DeJesus, Edwin, Sloan, Louis, Lewis, Stanley T., Clay, Patrick G., Bellos, Nicholaos C., Montero, Jose, Creticos, Catherine, Shamblaw, David, Valdes, Martin, Felizarta, Franco Antonio, Slim, Jihad, Lalezari, Jacob Paul, Ruane, Peter Jerome, Cade, Jerry L., Campo, Rafael E., Blick, Gary, Mayer, Cynthia, Daar, Eric, Kumar, Princy N., Swindells, Susan, Castro, Jose Guillermo, Santiago, Lizette, Santana-Bagur, Jorge L.

“…Doravirine is a novel non-nucleoside reverse transcriptase inhibitor (NNRTI) with a pharmacokinetic profile supporting once-daily dosing, and potent in-vitro…”
Get full text

Task sharing for managing common noncommunicable disease in a nurse led noncommunicable diseases clinic in peri-urban community of Chandigarh by Kashyap, Neha, Kavita, Kavita, Saini, Sushma, Singh, Amarjeet

“…Background: Nurse led noncommunicable diseases (NCD) clinic may address the significant shortage of human resource for health for managing common NCDs. The…”
Get full text

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial by Squires, Kathleen, Cahn, Pedro, Lombaard, Johan, DeJesus, Edwin, Lai, Ming-Tain, Rodgers, Anthony, Lupinacci, Lisa, Kumar, Sushma, Hwang, Carey, Martin, Elizabeth Anne, Osiyemi, Olayemi O., Prelutsky, David James, Scarsella, Anthony John, Dretler, Robin, DeJesus, Edwin, Sims, James, Clay, Patrick G., Bellos, Nicholaos C., Creticos, Catherine, Shamblaw, David, Mogyoros, Miguel, Terrelonge, Antonio E., Valdes, Martin, Tashima, Karen T., Robbins, William J., Felizarta, Franco Antonio, Elion, Richard A., Slim, Jihad, Lalla-Reddy, Sujata N., Mills, Anthony, Dietz, Craig A., Rubin, David Scott, Rondon, Juan Carlos, Cook, Paul P., Daar, Eric, Kumar, Princy N., Swindells, Susan, Castro, Jose Guillermo, Santiago, Lizette, Martins, Marcelo, Cahn, Pedro Enrique, Lopardo, Gustavo D., Porteiro, Norma, Baker, David Alfred, Roth, Norman, Finlayson, Robert James, McMahon, James, Rieger, Armin, Zangerle, Robert, Smaill, Fiona, Walmsley, Sharon L., Conway, Brian, Rachlis, Anita, Smith, Graham H.R., Afani, Alejandro, Chahin, Carolina Eugenia, Gerstoft, Jan, Weis, Nina, Laursen, Alex Lund, Molina, Jean-Michel, Cotte, Laurent, Raffi, Francois, Girard, Pierre-Marie, Katlama, Christine, Esser, Stefan, Stoll, Matthias, Schuermann, Dirk, Faetkenheuer, Gerd, Bogner, Johannes, Lutz, Thomas, Jaeger, Hans, Gori, Andrea, Coltan, Gabriel, Constandis, Felicia, Erscoiu, Simona Manuela, Prisacariu, Liviu-Jany, Rugina, Sorin, Pokrovsky, Vadim Valentinovich, Ryamova, Elena Pavlovna, Kulagin, Valeriy Viktorovich, Tsybakova, Olga Aleksandrovna, Voronin, Evgeniy, Shimonova, Tatyana Evgenyevna, Orrell, Catherine, de Jager, Marleen, Mallolas, Josep, Perez Elias, Maria Jesus, Gatell, Josep M., Arribas Lopez, Jose Ramon, Podzamczer Palter, Daniel, Pulido Ortega, Federico, Troya Garcia, Jesus, De los Santos Gil, Ignacio, Berenguer Berenguer, Juan, Johnson, Margaret A., Schembri, Gabriel, Clarke, Amanda, Gompels, Mark, Fox, Julie Meriel, Dockrell, David Harold

“…Doravirine is a novel, non-nucleoside reverse transcriptase inhibitor that has shown non-inferior efficacy to ritonavir-boosted darunavir, with a superior…”
Get full text

626. The Efficacy and Safety of Maintenance with Doravirine Plus Two NRTIs after Initial Suppression in Adults with HIV-1 in the DRIVE-FORWARD Clinical Trial: Results from the Study Extension through 192 Weeks by Cahn, Pedro, Molina, Jean-michel, Lombaard, Johan, Squires, Kathleen, Kumar, Sushma, Wan, Hong, Teal, Valerie, Asante-Appiah, Ernest, Sklar, Peter, Martin, Elizabeth A, Lahoulou, Rima

“…Abstract Background DRIVE-FORWARD is a phase 3 trial with a completed double-blind period comparing doravirine (DOR) 100 mg with ritonavir-boosted darunavir…”
Get full text